283
Views
20
CrossRef citations to date
0
Altmetric
Reviews

Targeting chemokines in proteinuria-induced renal disease

, PhD, , , , , , & show all
Pages 833-845 | Published online: 16 Jul 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maria Vanessa Perez-Gomez, Maria Dolores Sanchez-Niño, Ana Belen Sanz, Binbin Zheng, Catalina Martín-Cleary, Marta Ruiz-Ortega, Alberto Ortiz & Beatriz Fernandez-Fernandez. (2016) Targeting inflammation in diabetic kidney disease: early clinical trials. Expert Opinion on Investigational Drugs 25:9, pages 1045-1058.
Read now

Articles from other publishers (19)

Ajinath Kale, Anshima Sharma, Hans-Joachim Anders & Anil Bhanudas Gaikwad. (2023) Diabetes and Cardiorenal Complications: A Clinical Review of Existing Therapies and Novel Combinations, Focusing on SGLT2 Inhibitors. Current Diabetes Reviews 19:8.
Crossref
Nur Samsu. (2021) Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. BioMed Research International 2021, pages 1-17.
Crossref
Di Wu, Zhenxiang Yu, Songchen Zhao, Zhihui Qu, Weixia Sun & Yanfang Jiang. (2019) Lipid metabolism participates in human membranous nephropathy identified by whole-genome gene expression profiling. Clinical Science 133:11, pages 1255-1269.
Crossref
Guangyu Zhou, Guangda Xin, Wenlong Zhang & Xiaofei Zhang. (2019) Biomarker prediction for membranous nephropathy prognosis by microarray analysis. Nephrology 24:5, pages 526-533.
Crossref
Giovanni Targher & Christopher D. Byrne. (2017) Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nature Reviews Nephrology 13:5, pages 297-310.
Crossref
Marcela HerreraMagnus SöderbergAlan SabirshBarbara ValastroJohan MölneBeatriz Santamaria, Angela M. Valverde, Silvia GuionaudStephanie HeasmanAlison Bigley, Lutz JermutusCristina RondinoneMatthew CoghlanDavid BakerCarol Moreno Quinn. (2017) Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease. American Journal of Physiology-Renal Physiology 312:4, pages F748-F759.
Crossref
Esmeralda Castillo-Rodríguez, Soledad Pizarro-Sánchez, Ana Sanz, Adrian Ramos, Maria Sanchez-Niño, Catalina Martin-Cleary, Beatriz Fernandez-Fernandez & Alberto Ortiz. (2017) Inflammatory Cytokines as Uremic Toxins: “Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son”. Toxins 9:4, pages 114.
Crossref
Giovanni Musso, Maurizio Cassader, Solomon Cohney, Franco De Michieli, Silvia Pinach, Francesca Saba & Roberto Gambino. (2016) Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities. Diabetes Care 39:10, pages 1830-1845.
Crossref
Sara Paccosi, Matelda Giachi, Paola Di Gennaro, Angelo Guglielmotti & Astrid Parenti. (2016) The chemokine (C-C motif) ligand protein synthesis inhibitor bindarit prevents cytoskeletal rearrangement and contraction of human mesangial cells. Cytokine 85, pages 92-100.
Crossref
Y-h Taguchi. (2015) Identification of aberrant gene expression associated with aberrant promoter methylation in primordial germ cells between E13 and E16 rat F3 generation vinclozolin lineage. BMC Bioinformatics 16:S18.
Crossref
Maria D. Sanchez-Niño, Daniel Carpio, Ana Belen Sanz, Marta Ruiz-Ortega, Sergio Mezzano & Alberto Ortiz. (2015) Lyso-Gb3 activates Notch1 in human podocytes. Human Molecular Genetics 24:20, pages 5720-5732.
Crossref
Carolina Lavoz, Matilde Alique, Raquel Rodrigues-Diez, Janos Pato, Gyorgy Keri, Sergio Mezzano, Jesús Egido & Marta Ruiz-Ortega. (2015) Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway. The Journal of Pathology 236:4, pages 407-420.
Crossref
Maria Perez-Gomez, Maria Sanchez-Niño, Ana Sanz, Catalina Martín-Cleary, Marta Ruiz-Ortega, Jesus Egido, Juan Navarro-González, Alberto Ortiz & Beatriz Fernandez-Fernandez. (2015) Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade. Journal of Clinical Medicine 4:6, pages 1325-1347.
Crossref
Borja Quiroga, David Arroyo & Gabriel de Arriba. (2015) Present and Future in the Treatment of Diabetic Kidney Disease. Journal of Diabetes Research 2015, pages 1-13.
Crossref
Raquel Rodrigues-Díez, Sandra Rayego-Mateos, Macarena Orejudo, Luiz Stark Aroeira, Rafael Selgas, Alberto Ortiz, Jesús Egido & Marta Ruiz-Ortega. (2015) TGF-Beta Blockade Increases Renal Inflammation Caused by the C-Terminal Module of the CCN2. Mediators of Inflammation 2015, pages 1-10.
Crossref
Jai Prakash. (2015) Updates in the management of diabetic nephropathy. Clinical Queries: Nephrology 4:1-2, pages 9-14.
Crossref
Beatriz Fernandez-Fernandez, Alberto Ortiz, Carmen Gomez-Guerrero & Jesus Egido. (2014) Therapeutic approaches to diabetic nephropathy—beyond the RAS. Nature Reviews Nephrology 10:6, pages 325-346.
Crossref
María Concepción Izquierdo, Catalina Martin-Cleary, Beatriz Fernandez-Fernandez, Usama Elewa, María D. Sanchez-Niño, Juan Jesús Carrero & Alberto Ortiz. (2014) CXCL16 in kidney and cardiovascular injury. Cytokine & Growth Factor Reviews 25:3, pages 317-325.
Crossref
Juan Antonio Moreno, Sara Moreno, Alfonso Rubio-Navarro, Carmen Gómez-Guerrero, Alberto Ortiz & Jesús Egido. (2014) Role of chemokines in proteinuric kidney disorders. Expert Reviews in Molecular Medicine 16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.